āļŠāļāļļāļĨāđ€āļ‡āļīāļ™āļ„āļĢāļīāļ›āđ‚āļ•
āđāļ”āļŠāļšāļ­āļĢāđŒāļ”
āļāļēāļĢāļ§āļīāđ€āļ„āļĢāļēāļ°āļŦāđŒāļ—āļēāļ‡āđ€āļ—āļ„āļ™āļīāļ„
āļ•āļąāļ§āļāļĨāļēāļ‡āļāļēāļĢāđāļĨāļāđ€āļ›āļĨāļĩāđˆāļĒāļ™
āļāļēāļĢāļ‹āļ·āđ‰āļ­āļ‚āļēāļĒāļŠāļīāļ™āļ—āļĢāļąāļžāļĒāđŒāļ”āļīāļˆāļīāļ—āļąāļĨāđ‚āļ”āļĒāļœāđˆāļēāļ™āļ„āļ™āļāļĨāļēāļ‡:
āļāļēāļĢāļ‹āļ·āđ‰āļ­āļ‚āļēāļĒāļŠāļīāļ™āļ—āļĢāļąāļžāļĒāđŒāļ”āļīāļˆāļīāļ—āļąāļĨāđ‚āļ”āļĒāđ„āļĄāđˆāļĄāļĩāļ„āļ™āļāļĨāļēāļ‡:

āļĢāļēāļ„āļēāļŦāļļāđ‰āļ™ Abbott Laboratories
ABT
#96

āļŋ3,162.08
  

0.39%

Abbott Laboratories Info

āļĄāļđāļĨāļ„āđˆāļēāļŦāļĨāļąāļāļ—āļĢāļąāļžāļĒāđŒāļ•āļēāļĄāļĢāļēāļ„āļēāļ•āļĨāļēāļ”
āļŋ5.5T

0.39%

āļ›āļĢāļīāļĄāļēāļ“āļāļēāļĢāļ‹āļ·āđ‰āļ­āļ‚āļēāļĒāļĢāļēāļĒāļ§āļąāļ™
āļŋ16.34B
āđ€āļ§āđ‡āļšāđ„āļ‹āļ•āđŒ
āļ›āļĢāļ°āđ€āļ āļ—āļŠāļīāļ™āļ—āļĢāļąāļžāļĒāđŒ
Stock
āļžāļ™āļąāļāļ‡āļēāļ™
114000
āļāđˆāļ­āļ•āļąāđ‰āļ‡
Jan 1, 1888
āļ•āļĨāļēāļ”āļŦāļĨāļąāļāļ—āļĩāđˆāđƒāļŠāđ‰āļ‹āļ·āđ‰āļ­āļ‚āļēāļĒ
New York Stock Exchange
āļ­āļļāļ•āļŠāļēāļŦāļāļĢāļĢāļĄ
Pharmaceutical Preparations
āļŦāļĄāļēāļĒāđ€āļĨāļ‚āļ›āļĢāļ°āļˆāļģāļ•āļąāļ§
0000001800

āļ‚āđ‰āļ­āļĄāļđāļĨāļŦāļļāđ‰āļ™āļ—āļĩāđˆāđāļ›āļĨāļ‡āđ€āļ›āđ‡āļ™āđ‚āļ—āđ€āļ„āļ™

āļĢāļēāļ„āļēāđ€āļ‰āļĨāļĩāđˆāļĒāļ‚āļ­āļ‡āļŠāļīāļ™āļ—āļĢāļąāļžāļĒāđŒāļ—āļĩāđˆāđāļ›āļĨāļ‡āđ€āļ›āđ‡āļ™āđ‚āļ—āđ€āļ„āļ™
āļŋ3.19K
āļ„āļ§āļēāļĄāļ•āđˆāļēāļ‡āļ‚āļ­āļ‡āļĢāļēāļ„āļē
+āļŋ29.3(+0.93%)
āļĄāļđāļĨāļ„āđˆāļēāļ•āļĨāļēāļ”āļ‚āļ­āļ‡āļŠāļīāļ™āļ—āļĢāļąāļžāļĒāđŒāđƒāļ™āļĢāļđāļ›āđāļšāļšāđ‚āļ—āđ€āļ„āļ™
āļŋ1.05B

1.77%

āļ›āļĢāļīāļĄāļēāļ“āļ‹āļ·āđ‰āļ­āļ‚āļēāļĒāļŠāļīāļ™āļ—āļĢāļąāļžāļĒāđŒāđƒāļ™āļĢāļđāļ›āđāļšāļšāđ‚āļ—āđ€āļ„āļ™ (24 āļŠ.āļĄ.
āļŋ50.1M

3.07%

āļœāļđāđ‰āļ­āļ­āļ
āļŠāļąāļāļāļē
āļŠāļģāļĢāļ§āļˆ
āļĢāļ°āļšāļšāđāļ›āļĨāļ‡ ABT āđ€āļ›āđ‡āļ™ USD
ABT
THB
āļāļēāļĢāļ›āļĢāļ°āđ€āļĄāļīāļ™āļ›āļĢāļ°āļŠāļīāļ—āļ˜āļīāļ āļēāļžāļ•āđˆāļ­āļĢāļēāļ„āļē
āļ•āđˆāļģ
āļŋ3.13K
āļŠāļđāļ‡
āļŋ3.18K

āļāļģāļĨāļąāļ‡āđ‚āļŦāļĨāļ”āļ‚āđ‰āļ­āļĄāļđāļĨ

āđ‚āļ›āļĢāļ”āļĢāļ­āļŠāļąāļāļ„āļĢāļđāđˆ āđ€āļĢāļēāļāļģāļĨāļąāļ‡āđ‚āļŦāļĨāļ”āļ‚āđ‰āļ­āļĄāļđāļĨāđāļœāļ™āļ āļđāļĄāļī

Abbott Laboratories āļŠāļļāļĄāļŠāļ™

skeleton-white
 
 
 
 
 
 

About Abbott Laboratories

What is Abbott Laboratories?

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.

āļ‚āđ‰āļ­āļĄāļđāļĨāļĢāļēāļ„āļēāļŠāļ” Abbott Laboratories

The current price of Abbott Laboratories in the market is āļŋ3,162.08, with a 24-hour trading volume of āļŋ16.34B. The asset's market cap is āļŋ5.5T, after moving 0.39% in the last day.

Tokenized Abbott Laboratories is trading at āļŋ3,191.38, with a tokenized market cap of āļŋ1.05B and a 24-hour trading volume of āļŋ50.1M. The tokenized asset has moved 1.77% in the past 24 hours.